IMPACT BIOMEDICAL INC. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Impact Biomedical Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2023 to Q1 2024.
  • Impact Biomedical Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$712K, a 29.8% increase year-over-year.
  • Impact Biomedical Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$2.85M, a 27.2% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$712K +$302K +29.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q1 2023 -$1.01M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.